On February 15, Pilar de la Horadada joined the global observance of International Childhood Cancer Day, raising awareness about the challenges faced by affected families. As part of this initiative, ...

Survival depends on many factors, so no one can tell you exactly how long you’ll live. It depends on your individual condition, type of cancer, treatment and level of fitness. Survival for testicular ...

Cancer cells may cause body odors, but not odors that most people will notice. While some studies show dogs may be able to detect cancer smells, researchers are exploring the possibility of detecting ...

Itchy skin, or pruritus, can be a symptom of some cancers, including blood-related, skin, liver, gallbladder, and bile-duct cancer cancers. However, other causes of itching are more common. Itching ...

Gabby Petito’s mother and stepfather will be the featured speakers at this year’s Alternatives to Violence Purple Ribbon Breakfast in April, a yearly fundraiser for the Loveland nonprofit.

The Number of Grants for each Cancer Type may include grants not 100% focused on that type of cancer. For example, a grant that focuses 90% on breast cancer and 10% on prostate cancer will be counted ...

Antonio Jimeno, Professor and Director of the Head and Neck Cancer Program REHOVOT, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE ...

Antonio Jimeno, Professor and Director of the Head and Neck Cancer Program REHOVOT, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE ...

of the head and neck (R/M SCCHN), with the news pushing its shares up as much as 10% to 6.50 shekels. Purple Biotech's NT219 is a first-in-class small molecule drug designed to target key cancer ...

NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and neck cancer drugs pembrolizumab (Keytruda ...

Antonio Jimeno, Professor and Director of the Head and Neck Cancer Program REHOVOT, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT ...